Francisco Muruzábal

3.1k total citations · 1 hit paper
52 papers, 2.4k citations indexed

About

Francisco Muruzábal is a scholar working on Radiology, Nuclear Medicine and Imaging, Public Health, Environmental and Occupational Health and Urology. According to data from OpenAlex, Francisco Muruzábal has authored 52 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Radiology, Nuclear Medicine and Imaging, 29 papers in Public Health, Environmental and Occupational Health and 21 papers in Urology. Recurrent topics in Francisco Muruzábal's work include Ocular Surface and Contact Lens (29 papers), Corneal Surgery and Treatments (28 papers) and Periodontal Regeneration and Treatments (21 papers). Francisco Muruzábal is often cited by papers focused on Ocular Surface and Contact Lens (29 papers), Corneal Surgery and Treatments (28 papers) and Periodontal Regeneration and Treatments (21 papers). Francisco Muruzábal collaborates with scholars based in Spain, Mexico and United States. Francisco Muruzábal's co-authors include Eduardo Anitua, Marı́a A. Burrell, Javier Gómez‐Ambrosi, Gema Frühbeck, Gorka Orive, Jesús Merayo‐Lloves, María de la Fuente, Ana Cristina Riestra, Mikel Sánchez and Ronald M. Sánchez-Ávila and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and FEBS Letters.

In The Last Decade

Francisco Muruzábal

51 papers receiving 2.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation

2001 729 citations Gema Frühbeck, Javier Gómez‐Ambrosi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Francisco Muruzábal Spain	25	755	698	561	524	494	52	2.4k
Mehrnoosh Saghizadeh United States	29	1.1k 1.4×	1.7k 2.4×	40 0.1×	908 1.7×	1.1k 2.2×	60	4.3k
Shuichi Sato Japan	29	78 0.1×	115 0.2×	791 1.4×	225 0.4×	257 0.5×	143	2.6k
Kurt Hong United States	17	223 0.3×	57 0.1×	41 0.1×	784 1.5×	295 0.6×	36	3.1k
Farhatullah Syed United Kingdom	24	91 0.1×	92 0.1×	47 0.1×	303 0.6×	535 1.1×	32	1.6k
Arndt van Ophoven Germany	25	96 0.1×	275 0.4×	1.6k 2.8×	124 0.2×	734 1.5×	54	2.5k
Richard Converse United States	18	241 0.3×	544 0.8×	39 0.1×	100 0.2×	54 0.1×	28	2.2k
Mustafa Cihat Avunduk Türkiye	22	113 0.1×	89 0.1×	92 0.2×	115 0.2×	85 0.2×	113	1.2k
Hong Chen China	29	62 0.1×	98 0.1×	85 0.2×	158 0.3×	244 0.5×	142	2.6k
Sabrina Mattoli Italy	34	149 0.2×	91 0.1×	61 0.1×	2.5k 4.7×	166 0.3×	70	4.6k
Koji Inoue Japan	29	70 0.1×	132 0.2×	57 0.1×	151 0.3×	177 0.4×	183	2.7k

Countries citing papers authored by Francisco Muruzábal

Since Specialization

Citations

This map shows the geographic impact of Francisco Muruzábal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Muruzábal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Muruzábal more than expected).

Fields of papers citing papers by Francisco Muruzábal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Muruzábal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Muruzábal. The network helps show where Francisco Muruzábal may publish in the future.

Co-authorship network of co-authors of Francisco Muruzábal

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Muruzábal. A scholar is included among the top collaborators of Francisco Muruzábal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Muruzábal. Francisco Muruzábal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anitua, Eduardo, et al.. (2024). Biochemical and biomechanical characterization of an autologous protein-based fibrin sealant for regenerative medicine. Journal of Materials Science Materials in Medicine. 35(1). 15–15. 1 indexed citations

Anitua, Eduardo, Francisco Muruzábal, Sergio Recalde, Patricia Fernández‐Robredo, & Mohammad Hamdan Alkhraisat. (2024). Potential Use of Plasma Rich in Growth Factors in Age-Related Macular Degeneration: Evidence from a Mouse Model. Medicina. 60(12). 2036–2036.

Anitua, Eduardo, et al.. (2023). Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells. Current Eye Research. 48(5). 456–464. 13 indexed citations

Anitua, Eduardo, Francisco Muruzábal, María de la Fuente, et al.. (2023). PRGF Membrane with Tailored Optical Properties Preserves the Cytoprotective Effect of Plasma Rich in Growth Factors: In Vitro Model of Retinal Pigment Epithelial Cells. International Journal of Molecular Sciences. 24(13). 11195–11195. 4 indexed citations

Anitua, Eduardo, María de la Fuente, Jesús Merayo‐Lloves, & Francisco Muruzábal. (2022). Optimization of a Plasma Rich in Growth Factors Membrane for the Treatment of Inflammatory Ocular Diseases. Bioengineering. 9(10). 508–508. 5 indexed citations

Anitua, Eduardo, et al.. (2021). Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus. Expert Opinion on Biological Therapy. 22(1). 31–45. 25 indexed citations

Sánchez-Ávila, Ronald M., Francisco Muruzábal, Begoña Baamonde, et al.. (2021). Use of Plasma Rich in Growth Factors and ReGeneraTing Agent Matrix for the Treatment of Corneal Diseases. Vision. 5(3). 34–34. 5 indexed citations

Sánchez-Ávila, Ronald M., María Satué, Gorka Orive, et al.. (2021). Membrane of Plasma Rich in Growth Factors in Primary Pterygium Surgery Compared to Amniotic Membrane Transplantation and Conjunctival Autograft. Journal of Clinical Medicine. 10(23). 5711–5711. 8 indexed citations

Sánchez-Ávila, Ronald M., Francisco Muruzábal, Belén Alfonso-Bartolozzi, et al.. (2021). Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy. Medicine. 100(3). e24139–e24139. 5 indexed citations

10.

Anitua, Eduardo, Francisco Muruzábal, Ander Pino, et al.. (2021). Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum. International Journal of Molecular Sciences. 22(22). 12176–12176. 13 indexed citations

11.

Anitua, Eduardo, María de la Fuente, Francisco Muruzábal, & Jesús Merayo‐Lloves. (2020). Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technology. Experimental Eye Research. 203. 108402–108402. 7 indexed citations

12.

Anitua, Eduardo, Francisco Muruzábal, Ana Cristina Riestra, María de la Fuente, & Jesús Merayo‐Lloves. (2019). Galenic validation of plasma rich in growth factors eye drops.. SHILAP Revista de lepidopterología. 43(2). 45–49. 7 indexed citations

13.

Anitua, Eduardo, María de la Fuente, Francisco Muruzábal, et al.. (2018). Differential profile of protein expression on human keratocytes treated with autologous serum and plasma rich in growth factors (PRGF). PLoS ONE. 13(10). e0205073–e0205073. 6 indexed citations

14.

Sánchez-Ávila, Ronald M., Jesús Merayo‐Lloves, Ana Cristina Riestra, et al.. (2017). The Effect of Immunologically Safe Plasma Rich in Growth Factor Eye Drops in Patients with Sjögren Syndrome. Journal of Ocular Pharmacology and Therapeutics. 33(5). 391–399. 43 indexed citations

15.

Sánchez-Ávila, Ronald M., Jesús Merayo‐Lloves, Ana Cristina Riestra, et al.. (2017). Treatment of patients with neurotrophic keratitis stages 2 and 3 with plasma rich in growth factors (PRGF-Endoret) eye-drops. International Ophthalmology. 38(3). 1193–1204. 55 indexed citations

16.

Muruzábal, Francisco, María de la Fuente, Ana Cristina Riestra, et al.. (2015). Effects of autologous serum and plasma rich in growth factors (PRGF-Endoret) eye drops on ocular surface myofibroblast differentiation.. Investigative Ophthalmology & Visual Science. 56(7). 734–734. 1 indexed citations

17.

Orive, Gorka, Francisco Muruzábal, Ander Pino, & Eduardo Anitua. (2014). Biological stability of Plasma Rich in Growth Factors (PRGF-Endoret) eye drops at different temperature conditions for 24 hours.. Investigative Ophthalmology & Visual Science. 55(13). 4688–4688. 1 indexed citations

18.

Anitua, Eduardo, Francisco Muruzábal, Ander Pino, Jesús Merayo‐Lloves, & Gorka Orive. (2013). Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months. Cornea. 32(10). 1380–1386. 43 indexed citations

19.

Gómez‐Ambrosi, Javier, Sara Becerril, Amaia Rodrı́guez, et al.. (2004). Reduced adipose tissue mass and hypoleptinemia in iNOS deficient mice: effect of LPS on plasma leptin and adiponectin concentrations. FEBS Letters. 577(3). 351–356. 28 indexed citations

20.

Muruzábal, Francisco, Gema Frühbeck, Javier Gómez‐Ambrosi, Marta Archanco, & Marı́a A. Burrell. (2002). Immunocytochemical detection of leptin in non-mammalian vertebrate stomach. General and Comparative Endocrinology. 128(2). 149–152. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact